Nivalis Therapeutics (NVLS)

Add to Watchlists
Create an Alert
16.79 -0.18  -1.06% NASDAQ Aug 3, 17:01 Delayed 2m USD
View Full Chart
NVLS Price Chart
View All Performance Charts

NVLS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Nivalis Therapeutics is up N/A over the last year vs S&P 500 Total Return up 10.90%, Vertex Pharmaceuticals up 54.04%, and Spark Therapeutics up N/A.


NVLS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • IR Website:
  • HQ Country: United States
  • HQ State/Province: Colorado
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Nivalis Therapeutics Inc is engaged in developing small molecule therapeutics for the treatment of diseases such as cystic fibrosis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease and certain cardiovascular disorders.

NVLS Excel Add-In Codes

  • Name: =YCI("NVLS","name")
  • Description: =YCI("NVLS","description")
  • Sector: =YCI("NVLS","sector")
  • Industry: =YCI("NVLS","industry")
  • Est. Current Fiscal Year End: =YCI("NVLS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.